샘플 요청 목록

 카트 문의
시장보고서
상품코드
1513934

세계의 신장결석 관리 기기 시장

Kidney Stone Management Devices
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 196 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

신장결석 관리 기기 세계 시장은 2030년까지 23억 달러에 달할 전망

2023년에 17억 달러로 추정되는 신장 결석 관리 기기 세계 시장은 분석 기간 2023-2030년에 CAGR 4.8%로 성장하고, 2030년에는 23억 달러에 이를 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 요관경 검사는 CAGR 5.4%로 성장을 지속하고, 분석 기간이 끝날 때까지 13억 달러에 달할 것으로 예측됩니다. 결석 파쇄기 부문의 성장률은 분석 기간 동안 CAGR 4.3%로 추정됩니다.

미국 시장은 4억 4,660만 달러, 중국은 CAGR 8.1%로 성장 예측

미국 신장 결석 관리 기기 시장은 2023년 4억 4,660만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2023-2030년간 CAGR 8.1%로 성장을 지속하여 2030년에는 4억 9,450만 달러 규모에 이를 것으로 예측되고 있습니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 2.4%와 3.9%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 3.1%로 성장할 것으로 예측됩니다.

신장 결석 관리 기기 - 주요 동향 및 촉진요인

신장 결석 관리 기기는 세계 수백만 명이 앓고있는 일반적인 비뇨기과 질환 인 신장 결석을 진단, 치료 및 관리하도록 설계된 전문 의료기기입니다. 이러한 기기에는 체외 충격파 결석 파쇄 기기(ESWL), 요관경, 신경, 레이저 결석 파쇄 기기, 스텐트 등 다양한 기술과 기구가 포함됩니다. ESWL 기기는 충격파로 신결석을 미세하게 부수고 자연스럽게 통과할 수 있도록 합니다. 요관경과 신경은 각각 요로와 신장의 결석을 직접 시각화하여 제거할 수 있는 내시경 기기입니다. 레이저 결석 파쇄 기기는 레이저 에너지를 이용하여 결석을 파쇄하는 것으로, 정밀하고 저침습적인 치료법입니다. 스텐트는 결석 제거 또는 파쇄 후 소변 흐름을 보장하고 합병증을 예방하고 회복을 돕는 데 사용됩니다. 이 기기는 결석의 크기, 위치 및 성분에 맞는 효과적인 치료법을 제공하는 데 매우 중요합니다.

의료 기술의 진보와 환자 관리 접근 방식의 변화를 반영하여 신장 결석 관리 기기 시장은 몇 가지 동향에 의해 형성됩니다. 중요한 동향 중 하나는 회복 시간의 단축과 합병증 발생률의 저하에 대한 환자의 요망으로부터 저침습 수술의 채용이 증가하고 있다는 것입니다. 이 때문에 최소한의 불쾌감과 정확하고 효율적인 결석 제거를 가능하게 하는 연성 요관경과 레이저 쇄석기의 사용이 증가하고 있습니다. 기술의 진보는 ESWL 기기의 능력을 높이고 정확성과 효과를 향상시킵니다. 초음파 검사나 투시 검사 등의 영상 기술을 결석 관리 기기에 통합함으로써 결석의 시각화와 표적의 좁힐 수 있게 되는 것도 주목해야 할 동향입니다. 게다가 식생활과 비만 등의 라이프스타일 요인도 있고 신장결석의 유병률이 상승하고 있는 것도 고급 관리 솔루션 수요를 밀어 올리고 있습니다. 게다가 스텐트 설계의 혁신은 스텐트와 관련된 불편함과 합병증을 줄이고 환자 결과를 개선하고 있습니다.

신장 결석 관리 기기 시장의 성장은 여러 요인에 의해 야기됩니다. 기술의 진보는 결석 제거 절차의 정확성, 효율성 및 안전성을 향상시키고, 보다 폭넓은 환자에게 보다 이용하기 쉽고 효과적이 되고 있습니다. 식생활의 변화, 탈수, 앉지 않은 생활 방식에 힘입어 신장 결석의 유병률 증가는 효과적인 관리 솔루션의 필요성을 확대하고 있습니다. 또한 신장 결석증에 대한 인식 증가와 고급 치료 옵션의 가용성으로 인해 더 많은 환자가 적시에 의료 개입을 요구할 수 있습니다. 또, 저침습 수술의 동향도 큰 추진력이 되고 있습니다. 이러한 수술은 통증의 경감, 입원 기간의 단축, 회복 시간의 단축을 가져오기 때문입니다. 헬스케어 제공업체는 환자의 케어와 치료 성적의 향상을 위해 이러한 첨단 기기를 채용하고 있습니다. 게다가 휴대가능하고 사용이 편리한 기기의 개발에 의해 외래 환자나 후진 지역에서도 신결석 관리가 보다 친숙해지고 있습니다. 신결석 치료에 대한 정부의 지원과 유리한 상환 정책은 시장 성장을 더욱 강화하고 있습니다. 전반적으로 이러한 요인은 신장 결석 관리 기기 시장의 견조한 성장을 가속하고 효과적이고 효율적인 치료 옵션에 대한 수요 증가에 부응하고 있습니다.

조사 대상 기업 예(총 48건)

  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Coloplast Group
  • Cook Medical
  • DirexGroup
  • Dornier MedTech
  • EMS Electro Medical Systems SA
  • EDAP TMS SA
  • Lumenis Ltd.
  • Olympus Corporation
  • Richard Wolf GmbH
  • Siemens Healthineers
  • Storz Medical AG

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

JHS 24.07.24

Global Kidney Stone Management Devices Market to Reach US$2.3 Billion by 2030

The global market for Kidney Stone Management Devices estimated at US$1.7 Billion in the year 2023, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Ureteroscopy, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Lithotripsy segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$446.6 Million While China is Forecast to Grow at 8.1% CAGR

The Kidney Stone Management Devices market in the U.S. is estimated at US$446.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$494.5 Million by the year 2030 trailing a CAGR of 8.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 3.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Kidney Stone Management Devices - Key Trends and Drivers

Kidney stone management devices are specialized medical tools designed to diagnose, treat, and manage kidney stones, a common urological condition affecting millions worldwide. These devices encompass a range of technologies and instruments, including extracorporeal shock wave lithotripsy (ESWL) machines, ureteroscopes, nephroscopes, laser lithotripters, and stents. ESWL machines use shock waves to break down kidney stones into smaller fragments that can be passed naturally. Ureteroscopes and nephroscopes are endoscopic devices that allow for the direct visualization and removal of stones within the urinary tract and kidney, respectively. Laser lithotripters utilize laser energy to fragment stones, offering a minimally invasive solution with high precision. Stents are used to ensure the free flow of urine after the removal or fragmentation of stones, preventing complications and aiding recovery. These devices are critical in providing effective treatment options tailored to the size, location, and composition of kidney stones.

Several trends are shaping the kidney stone management devices market, reflecting advancements in medical technology and changes in patient care approaches. One significant trend is the increasing adoption of minimally invasive procedures, driven by patient demand for reduced recovery times and lower complication rates. This has led to the growing use of flexible ureteroscopes and laser lithotripters, which allow for precise and efficient stone removal with minimal discomfort. Technological advancements are also enhancing the capabilities of ESWL machines, improving their accuracy and effectiveness. The integration of imaging technologies, such as ultrasound and fluoroscopy, with stone management devices is another notable trend, enabling better visualization and targeting of stones. Additionally, the rise in the prevalence of kidney stones, partly due to lifestyle factors such as diet and obesity, is driving the demand for advanced management solutions. Furthermore, innovations in stent design are improving patient outcomes by reducing stent-related discomfort and complications.

The growth in the kidney stone management devices market is driven by several factors. Technological advancements are enhancing the precision, efficiency, and safety of stone removal procedures, making them more accessible and effective for a broader range of patients. The increasing prevalence of kidney stones, fueled by dietary changes, dehydration, and sedentary lifestyles, is expanding the need for effective management solutions. Additionally, the growing awareness of kidney stone disease and the availability of advanced treatment options are encouraging more patients to seek timely medical intervention. The trend towards minimally invasive surgeries is also a significant driver, as these procedures offer reduced pain, shorter hospital stays, and quicker recovery times. Healthcare providers are increasingly adopting these advanced devices to improve patient care and outcomes. Moreover, the development of portable and user-friendly devices is making kidney stone management more accessible in outpatient settings and less developed regions. Government support and favorable reimbursement policies for kidney stone treatments are further propelling market growth. Overall, these factors are fostering robust growth in the kidney stone management devices market, meeting the rising demand for effective and efficient treatment options.

Select Competitors (Total 48 Featured) -

  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Coloplast Group
  • Cook Medical
  • DirexGroup
  • Dornier MedTech
  • E.M.S. Electro Medical Systems S.A.
  • EDAP TMS SA
  • Lumenis Ltd.
  • Olympus Corporation
  • Richard Wolf GmbH
  • Siemens Healthineers
  • Storz Medical AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Kidney Stone Management Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Kidney Stones Drives Demand for Advanced Management Solutions
    • Increasing Adoption of Minimally Invasive Procedures Propels Growth in Kidney Stone Management Devices
    • Technological Advancements in ESWL Machines Strengthen Business Case for Non-Invasive Treatments
    • Integration of Imaging Technologies Expands Addressable Market Opportunity for Precision Stone Removal
    • Innovations in Stent Design Here's How They Improve Patient Outcomes and Reduce Complications
    • Lifestyle Factors Such as Diet and Obesity Spur Growth in Kidney Stone Management Market
    • Growing Awareness of Kidney Stone Disease Generates Demand for Timely Medical Interventions
    • Development of Flexible Ureteroscopes Drives Adoption of Efficient Stone Removal Techniques
    • Increasing Use of Laser Lithotripters: Here's the Story for Precision and Minimal Discomfort in Stone Management
    • Trend towards Outpatient Procedures Expands Market Reach for Portable and User-Friendly Devices
    • Advances in Endoscopic Technologies Spur Growth in Efficient and Effective Stone Removal Solutions
    • Consumer Demand for Reduced Recovery Times and Lower Complication Rates Drives Minimally Invasive Techniques
    • Expansion of Urology Clinics and Specialized Healthcare Centers Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Kidney Stone Management Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Kidney Stone Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Ureteroscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Ureteroscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Ureteroscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Lithotripsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Lithotripsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Lithotripsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Percutaneous Nephrolithonomy (PCNL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Percutaneous Nephrolithonomy (PCNL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Percutaneous Nephrolithonomy (PCNL) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Kidney Stone Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Kidney Stone Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • INDIA
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Kidney Stone Management Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Kidney Stone Management Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Kidney Stone Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • AFRICA
    • Kidney Stone Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Kidney Stone Management Devices by Treatment Type - Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Kidney Stone Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Ureteroscopy, Lithotripsy and Percutaneous Nephrolithonomy (PCNL) for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Kidney Stone Management Devices by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Kidney Stone Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제